Titan Pharmaceuticals Inc.

TTNP | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.34

-$0.30 (-11.36%)

At close: Dec 16, 2025, 1:46 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Cash & Equivalents	328K	2.83M	6.76M	2.94M	6.04M	5.41M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	486K	n/a	n/a	48K	48K	-759K
Receivables	3.22M	62K	1.05M	36K	112K	884K
Inventory	n/a	n/a	n/a	106K	293K	328K
Other Current Assets	169K	30K	212K	524K	307K	181K
Total Current Assets	3.71M	2.92M	8.02M	3.6M	7.23M	7.33M
Property-Plant & Equipment	5K	n/a	68K	407K	717K	759K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	491K	n/a	68K	455K	765K	759K
Total Assets	4.21M	2.92M	8.09M	4.06M	7.99M	8.09M
Account Payables	77K	202K	348K	695K	795K	1.25M
Deferred Revenue	n/a	n/a	12K	196K	295K	533K
Short-Term Debt	n/a	n/a	500K	n/a	n/a	477K
Other Current Liabilities	2.57M	n/a	n/a	129K	1.14M	1.81M
Total Current Liabilities	2.65M	483K	1.44M	2.63M	2.67M	4.22M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	332K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	65K	187K	332K
Total Liabilities	2.65M	483K	1.44M	2.7M	2.86M	4.56M
Total Debt	n/a	n/a	565K	187K	299K	809K
Book Value	1.56M	2.44M	6.64M	1.36M	5.14M	3.53M
Book Value Per Share	1.84K	2.71	8.83	2.03	2.57	1.77
Common Stock	n/a	1K	1K	1K	10K	7K
Retained Earnings	-399.02M	-396.54M	-391.83M	-386.26M	-376.06M	-367.28M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	1.56M	2.44M	6.64M	1.36M	5.14M	3.53M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a